NS · Healthcare

Ishita Drugs & Industries Ltd (524400)

Pharmaceuticals & Biotechnology

Ishita Drugs & Industries Ltd (524400) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $233.10M, P/E ratio is 29.62, net margin is 5.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 524400

Market cap
$233.10M
P/E ratio
29.62
Net margin
5.2%

Ishita Drugs & Industries Ltd (524400) — FAQ

What is Ishita Drugs & Industries Ltd's market cap?

Ishita Drugs & Industries Ltd (524400) has a reported market cap of $233.10M (data as of 2026-07-10).

What is 524400's P/E ratio?

The price-to-earnings (P/E) ratio for Ishita Drugs & Industries Ltd (524400) is 29.62 (data as of 2026-07-10).

Does Ishita Drugs & Industries Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Ishita Drugs & Industries Ltd (524400). Check the MyAverix Finance app for the latest dividend data.

What sector is Ishita Drugs & Industries Ltd in?

Ishita Drugs & Industries Ltd (524400) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 524400 listed on?

524400 is listed on NS.

What is Ishita Drugs & Industries Ltd's net margin?

Ishita Drugs & Industries Ltd (524400) reports a net margin of 5.2% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play